PortfoliosLab logo
RDUS vs. TSLA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RDUS and TSLA is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

RDUS vs. TSLA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Radius Health, Inc. (RDUS) and Tesla, Inc. (TSLA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

RDUS:

0.58

TSLA:

1.03

Sortino Ratio

RDUS:

2.50

TSLA:

1.74

Omega Ratio

RDUS:

1.34

TSLA:

1.21

Calmar Ratio

RDUS:

0.79

TSLA:

1.15

Martin Ratio

RDUS:

3.28

TSLA:

2.83

Ulcer Index

RDUS:

20.70%

TSLA:

23.92%

Daily Std Dev

RDUS:

118.61%

TSLA:

72.07%

Max Drawdown

RDUS:

-88.18%

TSLA:

-73.63%

Current Drawdown

RDUS:

-60.93%

TSLA:

-37.84%

Fundamentals

Market Cap

RDUS:

$827.45M

TSLA:

$960.68B

EPS

RDUS:

-$9.99

TSLA:

$1.74

PEG Ratio

RDUS:

1.55

TSLA:

4.29

PS Ratio

RDUS:

0.30

TSLA:

10.04

PB Ratio

RDUS:

1.53

TSLA:

11.92

Total Revenue (TTM)

RDUS:

$2.74B

TSLA:

$95.72B

Gross Profit (TTM)

RDUS:

$158.46M

TSLA:

$16.91B

EBITDA (TTM)

RDUS:

-$199.86M

TSLA:

$13.96B

Returns By Period

In the year-to-date period, RDUS achieves a 97.11% return, which is significantly higher than TSLA's -26.14% return. Over the past 10 years, RDUS has underperformed TSLA with an annualized return of 8.81%, while TSLA has yielded a comparatively higher 33.91% annualized return.


RDUS

YTD

97.11%

1M

1.87%

6M

52.03%

1Y

66.54%

5Y*

17.83%

10Y*

8.81%

TSLA

YTD

-26.14%

1M

18.17%

6M

-7.15%

1Y

77.04%

5Y*

40.86%

10Y*

33.91%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RDUS vs. TSLA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDUS
The Risk-Adjusted Performance Rank of RDUS is 8383
Overall Rank
The Sharpe Ratio Rank of RDUS is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of RDUS is 9191
Sortino Ratio Rank
The Omega Ratio Rank of RDUS is 9090
Omega Ratio Rank
The Calmar Ratio Rank of RDUS is 8080
Calmar Ratio Rank
The Martin Ratio Rank of RDUS is 8080
Martin Ratio Rank

TSLA
The Risk-Adjusted Performance Rank of TSLA is 8282
Overall Rank
The Sharpe Ratio Rank of TSLA is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of TSLA is 8282
Sortino Ratio Rank
The Omega Ratio Rank of TSLA is 7777
Omega Ratio Rank
The Calmar Ratio Rank of TSLA is 8686
Calmar Ratio Rank
The Martin Ratio Rank of TSLA is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RDUS vs. TSLA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Radius Health, Inc. (RDUS) and Tesla, Inc. (TSLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current RDUS Sharpe Ratio is 0.58, which is lower than the TSLA Sharpe Ratio of 1.03. The chart below compares the historical Sharpe Ratios of RDUS and TSLA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

RDUS vs. TSLA - Dividend Comparison

RDUS's dividend yield for the trailing twelve months is around 2.56%, while TSLA has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
RDUS
Radius Health, Inc.
2.56%4.93%2.49%2.45%1.44%2.35%3.46%3.48%2.24%2.92%5.22%3.32%
TSLA
Tesla, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

RDUS vs. TSLA - Drawdown Comparison

The maximum RDUS drawdown since its inception was -88.18%, which is greater than TSLA's maximum drawdown of -73.63%. Use the drawdown chart below to compare losses from any high point for RDUS and TSLA. For additional features, visit the drawdowns tool.


Loading data...

Volatility

RDUS vs. TSLA - Volatility Comparison

The current volatility for Radius Health, Inc. (RDUS) is 1.50%, while Tesla, Inc. (TSLA) has a volatility of 18.43%. This indicates that RDUS experiences smaller price fluctuations and is considered to be less risky than TSLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

RDUS vs. TSLA - Financials Comparison

This section allows you to compare key financial metrics between Radius Health, Inc. and Tesla, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20212022202320242025
642.51M
19.34B
(RDUS) Total Revenue
(TSLA) Total Revenue
Values in USD except per share items

RDUS vs. TSLA - Profitability Comparison

The chart below illustrates the profitability comparison between Radius Health, Inc. and Tesla, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
4.3%
16.3%
(RDUS) Gross Margin
(TSLA) Gross Margin
RDUS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Radius Health, Inc. reported a gross profit of 27.50M and revenue of 642.51M. Therefore, the gross margin over that period was 4.3%.

TSLA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tesla, Inc. reported a gross profit of 3.15B and revenue of 19.34B. Therefore, the gross margin over that period was 16.3%.

RDUS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Radius Health, Inc. reported an operating income of -28.68M and revenue of 642.51M, resulting in an operating margin of -4.5%.

TSLA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tesla, Inc. reported an operating income of 399.00M and revenue of 19.34B, resulting in an operating margin of 2.1%.

RDUS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Radius Health, Inc. reported a net income of -32.98M and revenue of 642.51M, resulting in a net margin of -5.1%.

TSLA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tesla, Inc. reported a net income of 409.00M and revenue of 19.34B, resulting in a net margin of 2.1%.